20 companies

Mereo BioPharma Group

Market Cap: US$47.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States.

New

MREO

US$0.30

7D

-13.5%

1Y

-80.6%

Grace Therapeutics

Market Cap: US$44.8m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

GRCE

US$2.13

7D

2.4%

1Y

-33.9%

PDS Biotechnology

Market Cap: US$43.3m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

PDSB

US$0.78

7D

13.0%

1Y

-30.2%

Dyadic International

Market Cap: US$36.4m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

DYAI

US$1.00

7D

-4.8%

1Y

6.7%

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

BIOQ

US$32.50

7D

0%

1Y

n/a

Earth Science Tech

Market Cap: US$28.2m

Together with its subsidies, focuses on health and wellness industry.

New

ETST

US$0.098

7D

-10.9%

1Y

-49.8%

BioXcel Therapeutics

Market Cap: US$27.8m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

BTAI

US$0.90

7D

11.6%

1Y

-77.7%

MariMed

Market Cap: US$27.3m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

MRMD

US$0.068

7D

7.5%

1Y

-30.5%

TherapeuticsMD

Market Cap: US$24.0m

Operates as a pharmaceutical royalty company in the United States and internationally.

TXMD

US$2.07

7D

2.0%

1Y

95.0%

MDxHealth

Market Cap: US$23.7m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

MDXH

US$0.46

7D

10.3%

1Y

-82.7%

Actinium Pharmaceuticals

Market Cap: US$23.5m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

ATNM

US$0.79

7D

-6.0%

1Y

-49.6%

Cellectar Biosciences

Market Cap: US$20.5m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

CLRB

US$2.57

7D

0%

1Y

-45.7%

Jasper Therapeutics

Market Cap: US$18.5m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.

JSPR

US$0.65

7D

4.1%

1Y

-76.3%

Biofrontera

Market Cap: US$16.3m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

BFRI

US$1.27

7D

8.5%

1Y

34.2%

Bio Essence

Market Cap: US$13.5m

Engages in manufacturing and distributing health supplement products.

BIOE

US$0.25

7D

-7.5%

1Y

163.2%

Pharma-Bio Serv

Market Cap: US$13.3m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

PBSV

US$0.58

7D

37.3%

1Y

-3.3%

Traws Pharma

Market Cap: US$8.1m

A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.

TRAW

US$0.53

7D

18.2%

1Y

-64.5%

CordovaCann

Market Cap: US$4.4m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

LVRL.F

US$0.04

7D

-19.0%

1Y

-11.5%

Ayurcann Holdings

Market Cap: US$58.4k

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

AYUR.F

US$0.0003

7D

0%

1Y

-98.3%

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.

SIGO

US$0.0001

7D

0%

1Y

0%